| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.579 | 0.654 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
actin related protein T1 | 0.711 | 0.308 | 3.7E-03 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
betaine--homocysteine S-methyltransferase | 0.595 | 0.731 | 3.7E-14 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2000 | 2000 | ||||||||
|
abl interactor 2 | 0.700 | 0.423 | 0.43 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
group | 0.010 | None | < 0.001 | 1 | 1 | 2006 | 2006 | ||||||||
|
DAB2 interacting protein | 0.588 | 0.538 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
high mobility group AT-hook 1 | 0.494 | 0.769 | 0.83 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
baculoviral IAP repeat containing 3 | 0.491 | 0.769 | 6.6E-02 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
tripartite motif containing 63 | 0.617 | 0.538 | 4.3E-13 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
cytochrome P450 family 2 subfamily C member 9 | 0.506 | 0.885 | 1.3E-10 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
keratin 90 pseudogene | 0.751 | 0.423 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | |||||||||
|
ADP ribosylation factor like GTPase 6 interacting protein 1 | 0.653 | 0.577 | 2.2E-02 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
programmed cell death 6 interacting protein | 0.663 | 0.500 | 0.71 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
WD repeat domain 1 | 0.623 | 0.654 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
F-box protein 32 | 0.636 | 0.615 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2012 | 2017 | ||||||||
|
purinergic receptor P2Y12 | 0.533 | 0.731 | 1.7E-03 |
|
group | 0.020 | None | 0.500 | 2 | 1 | 2008 | 2013 | ||||||||
|
alpha 2-HS glycoprotein | 0.506 | 0.846 | 3.2E-10 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2007 | 2016 | ||||||||
|
allograft inflammatory factor 1 | 0.521 | 0.808 | 1.9E-06 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2006 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily M member 7 | 0.531 | 0.731 | 5.2E-16 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2008 | 2017 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 1998 | 2008 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2001 | 2017 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase | 0.482 | 0.808 | 2.4E-12 |
|
group | 0.040 | None | 0.750 | 4 | 1 | 1997 | 2007 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2001 | 2009 |